Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Cis-dichlorodiammineplatinum(II) (DDP) was paired with 11 other chemotherapeutic drugs in a search for possible synergistic pairs. Cell lethality was investigated by the colony-formation technique utilizing a long-term culture of human lymphoma cells. Synergistic effects were noted for pair combinations with all alkylating agents, bleomycin, adriamycin, camptothecin, and cytosine arabinoside. Additive effects were recorded for combinations with prednisolone and VP-16-213, while DDP reduced the capacity of cells to absorb sublethal damage induced by alkylating agents.
D000477:Alkylating Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002945:Cisplatin / Q000494:pharmacology*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008223:Lymphoma / Q000378:metabolism*; D009607:Nitrosourea Compounds / Q000494:pharmacology
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D004338:Drug Combinations; D009607:Nitrosourea Compounds; D002945:Cisplatin